TheEdgeResearch
Home / Stocks / AVAI

Avai Bio, Inc. (AVAI)

OTC Technology Software - Application
$0.12 ▲ +8.35%
Market Cap
$16.9M
Sector
Technology
Industry
Software - Application
Beta
0.87
52-Wk Range
0.11-0.8
CEO
Chris Winter
Country
US
Currency
USD

Avai Bio, Inc. operates in the Software - Application industry of the Technology sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.12, up 8.35% on the session, giving a market capitalisation of $16.9M. On trailing twelve-month figures it carries a trailing P/E of -9.68, a net margin of 0.0%. Its beta of 0.87 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-9.68
Price / Sales
0.00
Price / Book
-6.05
EV / EBITDA
-12.25
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.64
Current ratio
0.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2020-04-06
Headquarters
Las Vegas, NV, US
About Avai Bio, Inc.

Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public. The company was established on November 6, 2017, and its main office is situated in Las Vegas, Nevada.

Comparable companies

Avai Bio, Inc. is most often compared with the following Technology names:

BSKZFDGGXFFCGYINVUMHUBFNNVUFNYWKFQIFTFRAASYRPMT
More research on AVAI
AVAI technical analysis AVAI TheEdge Score Compare against peers
Open full interactive analysis & DCF →